Projects funded by the NCN
Uncovering the NK cell-dependent mechanisms of action of daratumumab in T-ALL
2024/53/N/NZ3/03752
Keywords:
acute lymphoblastic leukemia T-ALL daratumumab CD38 cell death
Descriptors:
- NZ5_7: Human disease treatment
- NZ3_3: Apoptosis
- NZ6_1: Adaptive and innate immunity
Panel:
NZ3 - Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 23 - announced on 2024-03-21
Amount awarded: 208 864 PLN
Project start date (Y-m-d): 2025-01-27
Project end date (Y-m-d): 2028-01-26
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.